FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) for KRW21.7 billion on February 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,310 KRW | +3.36% | +9.48% | -15.54% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,310 KRW | +3.36% | +9.48% | 55.8M | ||
1,174 KRW | -0.51% | -0.42% | 58.43M | ||
1st Jan change | Capi. | |
---|---|---|
-15.54% | 55.8M | |
+16.61% | 7.09B | |
-8.33% | 1.95B | |
-4.50% | 1.28B | |
-12.95% | 1.12B | |
-34.24% | 628M | |
-6.90% | 516M | |
-36.87% | 461M | |
+7.85% | 433M | |
-33.32% | 371M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion.